Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retinal Therapy Guided by 3D OCT Image Analysis

NCT02308215 is registered in ClinicalTrials.gov with Michael Abramoff as lead sponsor.

NCT NCT02308215
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02308215 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retinal Therapy Guided by 3D OCT Image Analysis
Lead sponsor
Michael Abramoff
Phase
Observational
Overall status
Completed
Start date
July 31, 2010
Completion date
July 5, 2018
Enrollment
77 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

age-related macular degeneration, choroidal neovascularization